Brainstorm Cell Therapeutics (BCLI) Q3 2025 Earnings

Aug 14Confirmed
Q3 2024
Q4 2024
Q2 2025
Q3 2025
-0.97
-0.45
0.08
0.6

Details

Expected EPS
-0.37
Actual EPS
-0.34
Surprise EPS
0.03
Surprise Percent
+8.11%

Description

⁨Brainstorm Cell Therapeutics⁩ (⁦BCLI⁩) has reported earnings of ⁦-0.34⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts